About US
Contact us
-
Vir, WuXi Biologics terminate COVID antibody pact as US rollout faces uncertain futureThe U.S. distribution of Vir Biotechnology’s GSK-partnered COVID-19 antibody has been put on hold for more than a month. Now, a collaborator in the therapy wants out. WuXi Biologics has returne2022/5/24
-
Quickly turning $23M into $10M, Zealand offloads insulin delivery tech to MannKindZealand Pharma hasfounda buyer for its V-Go insulin delivery device. Weeks after lackluster sales led it to seek a partner for the device, Zealand has agreed to offload the technology and associated2022/5/18
-
Buffett's Berkshire backs out of AbbVie, Bristol Myers Squibb holdingsAfter a gung-ho push into biopharma at the peak of the COVID-19 pandemic, Warren Buffett’s investment shop Berkshire Hathaway—more comfortable with tech stocks like Amazon and Apple—has hived off two2022/5/18
-
Valneva's COVID-19 vaccine faces uncertain future after Europe cancels supply contractWith Valneva’s inactivated COVID-19 vaccine candidate stalled in the regulatory process, the European Commission haspulledthe plug on its advance purchase agreement for the shot. Oncebelievedto2022/5/16
-
3rd time lucky? ScPharmaceuticals gets decision date for twice-rejected on-body drug delivery productScPharmaceuticals has an important new date for its calendar. With the FDAacceptingan approval filing for its on-body infusor heart failure therapy, scPharmaceuticals is set to learn whether the cand2022/5/16
-
Johnson & Johnson taps insiders to lead consumer health group after 2023 separationJohnson & Johnson is making headway toward its consumer health separation, and on Wednesday the company revealed the group's planned leadership. Thibaut Mongon will2022/5/12
-
Moderna's new CFO out the door after former employer discloses accounting probeThat was fast. Just a month after mRNA giant Moderna unveiled a CFO switch, its new finance chief is out the door because his former employer disclosed an internal accounting probe. Moderna's C2022/5/12
-
After 2 years, Sanofi's drug ingredients spinoff takes flightIt’s official: Two years and one pandemic after Sanofi unveiled plans to spin off its European drug ingredients business, EUROAPI has debuted on the Euronext exchange. Shares in the new active pharma2022/5/10
-
Enhertu's breast cancer nod; Biogen, Eisai's next play; FDA snubs 2 China-made cancer drugsWith a new FDA approval for Enhertu, AstraZeneca and Daiichi Sankyo are heaping pressure on Roche and Seagen. As Biogen terminates its Aduhelm marketing efforts, the focus has shifted to its second A2022/5/10
-
Marinus restarts phase 3 seizure trials after stability, COVID delaysMarinus Pharmaceuticals isrestartingits phase 3 seizure clinical trials that had been delayed by clinical supply disruptions and the COVID-19 pandemic. The company has r2022/5/6